HNRNPCL2: A Key Regulator of The Cell Cycle and Potential Drug & Biomarker Target in Cancer

Target Name: HNRNPCL2

NCBI ID: G440563

HNRNPCL2

HNRNPCL2: A Key Regulator of The Cell Cycle and Potential Drug & Biomarker Target in Cancer

Heterogeneous nuclear ribonucleoprotein C-like 2 (HNRNPCL2) is a protein that is expressed in a variety of tissues and cells in the human body. It is a key regulator of the cell cycle, and is involved in the development and progression of many diseases, including cancer.

HNRNPCL2 is a member of the heterogeneous nuclear ribonucleoprotein (HNRNA) family, which is a group of proteins that are involved in the regulation of gene expression. These proteins are made up of a combination of RNA and protein, and are found in a variety of cell types throughout the body.

One of the key functions of HNRNPCL2 is its role as a regulator of the cell cycle. The cell cycle is the process by which a cell grows, replicates its DNA, and divides. HNRNPCL2 is involved in the regulation of the different stages of the cell cycle, including the G1, S, G2, and M phases.

In addition to its role in regulating the cell cycle, HNRNPCL2 is also involved in the development and progression of many diseases, including cancer. For example, studies have shown that HNRNPCL2 is often expressed in a variety of cancer types, and that it is involved in the regulation of cell growth, angiogenesis, and the development of cancer stem cells.

HNRNPCL2 is also a potential drug target in cancer treatment. Because HNRNPCL2 is involved in the regulation of the cell cycle and has been shown to be involved in the development and progression of many diseases, it may be a useful target for cancer treatment. Studies have shown that inhibiting HNRNPCL2 may be effective in treating a variety of cancer types, including breast, ovarian, and colorectal cancers.

In addition to its potential as a drug target, HNRNPCL2 is also a potential biomarker for cancer. Because HNRNPCL2 is involved in the regulation of the cell cycle and is often expressed in many cancer types, it may be a useful biomarker for the diagnosis and treatment of cancer.

Overall, HNRNPCL2 is a complex protein that is involved in a variety of important functions in the cell. Its role as a regulator of the cell cycle and its potential as a drug target and biomarker make it an interesting target for further research and development.

Protein Name: Heterogeneous Nuclear Ribonucleoprotein C Like 2

Functions: May play a role in nucleosome assembly by neutralizing basic proteins such as A and B core hnRNPs

The "HNRNPCL2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HNRNPCL2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets